Jorge Vela-Ojeda

8PUBLICATIONS
14CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsHaematological tumoursMedical mycologyMedical infection agents (incl. prions)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 25, 2026
Outpatient Delivery of Step-Up Doses to Rapidly Initiate Monthly Doses of Bispecific Antibodies in Multiple Myeloma.

Aline G Ramírez-Alvarado, Ana Varela-Constantino, David Gómez-Almaguer

|Jan 28, 2026
IL-1β Controls Proliferation, Apoptosis, and Necroptosis Through the PI3K/AKT/Src/NF-κB Pathway in Leukaemic Lymphoblasts.

Zitlal-Lin Victoria-Avila, Elba Reyes-Maldonado, María Lilia Domínguez-López

|Dec 16, 2025
Multiple myeloma in Mexico: a retrospective study on long-term survival in a publicly insured cohort.

Juan Carlos Solis-Poblano, María Teresa Itzmoyotl-Hernández, Uendy Pérez-Lozano

|Oct 11, 2025
Mechanism regulation of endoplasmic reticulum stress in multiple myeloma cells: modulation of the UPR, UPS, autophagy, HSPs, and potential therapeutic targets.

Ruth Angélica Lezama, Alexis Gudiño García, Karla López Ramírez

|Jul 12, 2025
t(4;14), and revised myeloma comorbidity index as good predictors of survival for multiple myeloma.

Aline G Ramirez-Alvarado, Susana Gabriela Gonzalez-Prieto, Yael Solis-Aranda

|May 14, 2024
Soluble MIC-A, IPI, and response to treatment strongly predict survival in patients with germinal center diffuse large B cell lymphoma.

Jorge Vela-Ojeda, Ana Cristina Olivas-Bejarano, Laura Arcelia Montiel-Cervantes

Pageof 2